April 23, 2024 Experience TScan Therapeutics $150 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Market
April 23, 2024 Experience Cohen & Steers $100 million at-the-market offering The shares are listed on the NYSE
April 22, 2024 Experience Intra-Cellular Therapies $500 million stock offering The shares are listed on the Nasdaq Global Select Market
April 17, 2024 Experience Galaxy C$169.4 million offering of ordinary shares We advised Galaxy on its offering
April 16, 2024 Experience Nurix Therapeutics $175 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Market
April 12, 2024 Experience SoundHound AI $150 million at-the-market offering The shares are listed on the Nasdaq Global Market
April 10, 2024 Experience TD SYNNEX $606 million secondary offering The shares are listed on the NYSE
April 10, 2024 Experience Biodesix $55 million follow-on offering The common stock is listed on the Nasdaq Global Market
April 4, 2024 Experience Adagene $100 million at-the-market offering We advised Adagene on the offering
April 2, 2024 Experience Serena Energia R$775 million equity offering The shares are listed on the São Paulo Stock Exchange